Search

everythinglearnresearchcommunity

for

Search:↓

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone therapy increases bone density in older men with low testosterone levels.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Finasteride side effects in young men may be linked to specific gene variations.

Finasteride helps reduce heart enlargement in heart failure patients.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.